Nithin Krishna, MD
Psychiatry · Penfield, NYNPI 1891019881
Payments from drug & device makers
Across 132 payments — averaging $103.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neuronetics, Inc.$6K
- AbbVie$4K
- Biogen$2K
- Otsuka America Pharmaceutical, Inc.$386
- Johnson & Johnson$285
- Takeda Pharmaceuticals U.S.A., Inc.$149
- plus $697 from 13 others
What the payments were for
- Consulting fees$1,74013%
- Speaking & faculty fees$3,76027%
- Food & beverage$1,97014%
- Education$360%
- Other$6,16845%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neuronetics, Inc. | 6 | $6,286 |
| AbbVie(2 entities) | 34 | $4,131 |
| Biogen | 1 | $1,740 |
| Otsuka America Pharmaceutical, Inc. | 22 | $386 |
| Johnson & Johnson | 17 | $285 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $149 |
| Neurocrine Biosciences, Inc. | 7 | $112 |
| Lundbeck LLC | 6 | $92 |
| Shire North American Group Inc | 5 | $89 |
| Neos Therapeutics, LP | 5 | $72 |
| Avanir Pharmaceuticals, Inc. | 4 | $67 |
| Acadia Pharmaceuticals Inc | 3 | $51 |
| Bausch Health US, LLC | 3 | $46 |
| Teva Pharmaceuticals USA, Inc. | 3 | $44 |
| OWP Pharmaceuticals, Inc. | 3 | $35 |
| Jazz Pharmaceuticals Inc. | 2 | $27 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $25 |
| Ironshore Pharmaceuticals Inc. | 1 | $21 |
| Eisai Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEUROSTAR TMS THERAPY SYSTEM$6,168
- VRAYLAR$3,760
- ADUHELM$1,740
How this compares
$13,674 in reported general payments places this provider in the 90th percentile of 3,713 psychiatry providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Penfield
- Elyssa BarronWhite Plains$12.8M
- Mark DibuonoStaten Island$11.9M
- Ronald BrennerHempstead$11.5M
- Anton PorsteinssonRochester$7.6M
- Michael LiebowitzNew York$7.1M
- Leslie CitromePomona$5.7M
- John KaneGlen Oaks$4M
- Inna Yuryev-GolgerBrooklyn$3M
- Subhdeep VirkBuffalo$3M
- Paul EderNew York$2.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.